Syon Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Syon Capital's PFE Position: Q1 2026 in Review
Syon Capital reduced its Pfizer (PFE) stake by 3.8% in Q1 2026, selling an estimated $35.3K and leaving 33,704 shares worth $946K. The position accounts for 0.05% of the portfolio, ranked #324.
Syon Capital first reported a position in PFE in Q3 2023 and has held it in 11 quarters since. The position peaked at $3.71M in Q4 2023. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Syon Capital held 33,704 shares of Pfizer worth $946K as of Q1 2026.
- Syon Capital sold 1,326 Pfizer shares in Q1 2026, an estimated $35.3K.
- Pfizer made up 0.05% of Syon Capital's portfolio in Q1 2026, its #324 holding.
- Syon Capital first reported a position in Pfizer in Q3 2023 and has held it in 11 quarters since.
- Syon Capital's Pfizer position peaked at $3.71M in Q4 2023.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Syon Capital's 13F filing for Q1 2026, filed 13 May 2026.